DNMT3A and myelodysplastic syndrome: DNMT3A and TET2 are also candidate genes for CHIP mutations, as loss-of-function mutations in these genes are commonly detected in the peripheral blood samples of patients with myelodysplastic syndromes and acute myeloid leukemia (8).